Natalie Warner
Family · Weirton, WVNPI 1114534567
Payments from drug & device makers
Across 171 payments — averaging $34.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- Biohaven Pharmaceuticals, Inc.$1K
- UCB, Inc.$817
- Biohaven Pharmaceutical Holding Company Ltd.$601
- Biogen$401
- EMD Serono, Inc.$330
- plus $1K from 12 others
What the payments were for
- Travel & lodging$1,07918%
- Food & beverage$4,69080%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 11 | $1,592 |
| Biohaven Pharmaceuticals, Inc. | 34 | $1,059 |
| UCB, Inc. | 32 | $817 |
| Biohaven Pharmaceutical Holding Company Ltd. | 32 | $601 |
| Biogen | 8 | $401 |
| EMD Serono, Inc. | 14 | $330 |
| AstraZeneca | 10 | $328 |
| Lilly USA, LLC | 7 | $156 |
| Kyowa Kirin, Inc. | 7 | $143 |
| Sumitomo Pharma America, Inc. | 1 | $100 |
| AbbVie | 5 | $98 |
| Acorda Therapeutics, Inc | 3 | $71 |
| Argenx US, Inc. | 2 | $57 |
| Tanabe Pharma America, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Pfizer | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,388
- NURTEC ODT$461
- Briviact$125
- Vumerity$109
- ULTOMIRIS$103
- APTIOM$100
How this compares
$5,858 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $934 |
Paid to pharmacies, not to this prescriber.
Other family in Weirton
- Anthony ReesWeirton$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.